{{Distinguish|Bromadiolone}}

{{Drugbox
| Watchedfields = changed
| verifiedrevid = 462780619
| IUPAC_name = 4-bromo-N-[(1''S'',2''S'')-2-(dimethylamino)cyclohexyl]benzamide
| image = Bromadoline.svg
| chirality = [[Racemic mixture|Racemate]] of ''trans'' isomers
<!-- Clinical data -->
| tradename =
| pregnancy_category =
| legal_status =
| routes_of_administration =
<!-- Pharmacokinetic data -->
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 67579-24-2
| ATC_prefix = none
| ATC_suffix =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = R8DWN01P1M
| synonyms = Bromadoline
| PubChem = 54753
| ChEMBL = 2110893
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 49457
<!-- Chemical data -->
| C=15 | H=21 | Br=1 | N=2 | O=1
| molecular_weight = 325.244 g/mol
| smiles = CN([C@H]1CCCC[C@@H]1NC(C2=CC=C(C=C2)Br)=O)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H21BrN2O/c1-18(2)14-6-4-3-5-13(14)17-15(19)11-7-9-12(16)10-8-11/h7-10,13-14H,3-6H2,1-2H3,(H,17,19)/t13-,14-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UFDJFJYMMIZKLG-KBPBESRZSA-N
}}

'''Bromadoline''' (U-47931E)<ref>{{cite book | title = Unlisted Drugs | volume = 34–35 | page = 392 | date = 1982 | publisher = Pharmaceutical Section, Special Libraries Association | location = Chatham | isbn = 978-0-913210-13-0 }}</ref> is an [[opioid]] [[analgesic]] [[binding selectivity|selective]] for the [[μ-opioid receptor]]<ref name="pmid3559988">{{cite journal|first1=A. G.|last1=Hayes|first2=M.|last2=Skingle|first3=M. B.|last3=Tyers|title=Evaluation of the receptor selectivities of opioid drugs by investigating the block of their effect on urine output by beta-funaltrexamine.|url=http://jpet.aspetjournals.org/content/240/3/984.abstract|journal=Journal of Pharmacology and Experimental Therapeutics|date=1 March 1987|issn=1521-0103|pages=984–988|volume=240|issue=3|pmid=3559988}}</ref> developed by the Upjohn company in the 1970s.<ref>{{cite web | url=https://www.google.com/patents/US4098904 | title=Patent US4098904 - Analgesic N-(2-aminocycloaliphatic)benzamides | date=4 July 1978 | author=Jacob Szmuszkovicz | publisher=The Upjohn Company}}</ref>The drug has a potency lying between that of codeine and morphine, being slightly stronger than [[pentazocine]].<ref name="Hayes_1987">{{cite journal|first1=A.g.|last1=Hayes|first2=M.j.|last2=Sheehan|first3=M.b.|last3=Tyers | title = Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to μ-and κ-opioid receptor agonists | journal = British Journal of Pharmacology | volume = 91 | issue = 4 | pages = 823–832 | date= August 1987 | pmid = 2822190 | pmc = 1853585 | doi = 10.1111/j.1476-5381.1987.tb11281.x}}</ref> Bromadoline is related to [[AH-7921]] and [[U-47700]].<ref>{{cite journal | url=http://pubs.acs.org/doi/abs/10.1021/jm00150a017 | title=Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor |author1=B. Vernon Cheney |author2=Jacob Szmuszkovicz |author3=Robert A. Lahti |author4=Dominic A. Zichi | journal=Journal of Medicinal Chemistry | date=December 1985 | volume=28 | issue=12 | pages=1853–1864 | doi=10.1021/jm00150a017 | pmid=2999404}}</ref>

==See also==
* [[AH-7921]]
* [[U-47700]]
* [[Spiradoline]]
* [[U-50488]]

== References ==
{{Reflist|33em}}

{{Opioidergics}}

[[Category:Amines]]
[[Category:Benzamides]]
[[Category:Bromoarenes]]
[[Category:Synthetic opioids]]
[[Category:Mu-opioid agonists]]


{{nervous-system-drug-stub}}